Switch to:
More From Other Websites
FTC Puts Conditions on Lilly's Deal to Buy Novartis Unit Dec 22 2014
Lilly must divest Sentinel products after FTC nod on Novartis deal Dec 22 2014
Lilly must divest Sentinel products after FTC nod on Novartis deal Dec 22 2014
Lilly to divest some Sentinel products to win approval on Novartis Dec 22 2014
Lilly Announces Diabetes Research Partnership with University of Surrey Dec 22 2014
10:02 am Eli Lilly announces a five-year research partnership with the University of Surrey to study... Dec 22 2014
Lilly Announces Diabetes Research Partnership with University of Surrey Dec 22 2014
Lilly Announces Diabetes Research Partnership with University of Surrey Dec 22 2014
Beta-Amyloid: The Emperor Really Does Have No Clothes Dec 20 2014
Roche Drugs For Alzheimer's, Breast Cancer Disappoint Dec 19 2014
LILLY ELI & CO Files SEC form 8-K, Change in Directors or Principal Officers Dec 19 2014
Eli Lilly reaches insulin development deal with Adocia Dec 19 2014
Eli Lilly reaches insulin development deal with Adocia Dec 19 2014
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone... Dec 19 2014
Eli Lilly and Adocia agree to develop ultra-rapid insulin Dec 19 2014
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone... Dec 19 2014
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone... Dec 19 2014
Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial... Dec 17 2014
Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial... Dec 17 2014
Lilly's CYRAMZA® (ramucirumab) Receives Third FDA Approval Dec 16 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK